Proposed Data Collection Submitted for Public Comment and Recommendations, 75593-75594 [2023-24346]
Download as PDF
Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–24344 Filed 11–2–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–0006; Docket No. CDC–2023–
0090]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Statement in Support of
Application for Waiver of
Inadmissibility Under Immigration and
Nationality Act. This information
collection is related to waivers of
inadmissibility on health-related
grounds, specifically mental health
disorders with associated harmful
behavior.
DATES: CDC must receive written
comments on or before January 2, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0090 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:02 Nov 02, 2023
Jkt 262001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:
Proposed Project
Statement in Support of Application
for Waiver of Inadmissibility Under
Immigration and Nationality Act (OMB
Control No. 0920–0006, Exp. 12/31/
2023)—Revision—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
75593
Background and Brief Description
The goal of this proposed collection is
to provide Centers for Disease Control
and Prevention (CDC) with adequate
information to fulfill its responsibilities
with regard to the processing of
applications for waivers of
inadmissibility on health-related
grounds, specifically mental health
disorders with associated harmful
behaviors. Section 212 (a) of the
Immigration and Nationality Act (INA)
states that aliens with specific healthrelated grounds are ineligible to receive
visas and ineligible for admission into
the United States. The conditions are
listed in subsections as follows:
(i) aliens who have a communicable
disease of public health significance,
(iii) (I) aliens who have a physical or
mental disorder and behavior associated
with the disorder that may pose, or has
posed, a threat to the property, safety, or
welfare of the alien or others; or
(iii) (II) aliens who have had a
physical or mental disorder and a
history of behavior associated with the
disorder, which behavior has posed a
threat to property, safety, or welfare of
the alien or others and which behavior
is likely to recur or lead to other
harmful behavior.
However, section 212(g) of the INA
authorizes the Attorney General to
waive certain Class A inadmissible
health-related grounds which would
allow an alien to overcome his/her
inadmissibility. The CDC may provide
consultation to the U.S. Department of
Homeland Security (DHS) for requests
for waivers under section 212(a)(1)(A)(i)
or section 212(a)(1)(A)(iii)(I) or (II), as
indicated in the regulations (8 CFR
212.7 Waiver of certain grounds of
excludability) if: ‘‘the alien or the alien’s
sponsoring family member shall submit
a statement to the consular or Service
office. The statement must be from a
clinic, hospital, institution, school, or
other specialized facility or specialist in
the United States . . . who will
complete the evaluation and provide an
evaluation report to the Centers for
Disease Control and Prevention.’’
Waiver requests under section
212(a)(1)(A)(i) are processed on DHS
forms I–601 and I–602. Waiver requests
under section 212(a)(1)(A)(iii)(I) or (II)
are processed under CDC form 4.422–1.
Respondents to this data collection
include U.S. medical facilities and
specialists who complete Part II of CDC
form 4.422–1 for waiver applicants
based on physical or mental disorders
and submit the appropriate evaluation
report. Respondents also include the
applicant or sponsoring family member
E:\FR\FM\03NON1.SGM
03NON1
75594
Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Notices
who complete Part III of CDC form
4.422–1
CDC requests OMB approval for an
estimated 33 annual burden hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Total burden
(in hours)
Form name
Physician ...........................................
CDC 4.422–1 ...................................
200
1
10/60
33
Total ...........................................
...........................................................
........................
........................
........................
33
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–24346 Filed 11–2–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–23AX]
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSK11XQN23PROD with NOTICES1
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Assessing
Knowledge, Attitudes, and Practices
(KAPs) of Hispanic/Latina Women of
Reproductive Age (WRA) about Folic
Acid Fortification and
Supplementation’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on November
22, 2022, to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
VerDate Sep<11>2014
17:02 Nov 02, 2023
Jkt 262001
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Assessing Knowledge, Attitudes, and
Practices (KAPs) of Hispanic/Latina
Women of Reproductive Age (WRA)
about Folic Acid Fortification and
Supplementation—New—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Consuming 400 micrograms (mcg) of
folic acid daily in the periconceptional
period can reduce the risk of having a
pregnancy affected by a neural tube
defect (NTD), a severe birth defect of the
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
brain and spine. To increase the amount
of folic acid consumed in the U.S.
population, the U.S. Food and Drug
Administration (FDA) mandated
fortification of enriched cereal grain
products with folic acid in 1998.
Although strides have been made in
preventing neural tube defects, ethnic
disparities remain. Hispanic women in
the U.S. have the highest risk of having
a child affected by a NTD, with birth
prevalence of approximately seven
NTDs per 10,000 live births. In addition,
prior studies have found that Hispanic
women: (1) have lower levels of folate
in their blood compared to nonHispanic white women; (2) are more
likely than non-Hispanic white and
non-Hispanic black women to have the
MTHFR C677T gene variant; (3) are less
likely to know about the benefits of folic
acid; and (4) are less likely to get folic
acid from fortified foods or take a
multivitamin with folic acid in it,
particularly those women who primarily
speak Spanish, were born outside of the
United States, and have lived in the
United States for a shorter period of
time.
To effectively reach Hispanic women
of reproductive age (WRA) and increase
their knowledge and intake of folic acid
for NTD prevention, a contemporary
understanding of cultural factors in the
decision-making process and how these
women obtain information is needed.
Previous research highlighted important
nuances in potential cultural beliefs
regarding folic acid. A study of Spanishspeaking Hispanic women in the
southwest U.S. found no cultural
barriers to incorporating folic-acid rich
foods into their diets; however, focus
groups of Mexican American women
did find several cultural barriers. These
included: (1) misperceptions of the term
folic acid as an illegal substance, as the
word ‘‘acid’’ is like LSD; (2) its
importance for NTD prevention since
their healthcare providers did not talk to
them about folic acid; (3) its absence in
injectable form at the pharmacy; and (4)
mistaken belief that birth defects are not
preventable (resulting from an act of
E:\FR\FM\03NON1.SGM
03NON1
Provide the following information to help us resolve this problem: the URL of the page you were trying to access, the steps you followed to produce the error, specific search or browse terms, and/or a screenshot of the page where the error occurred.
© 2024 Justia
